Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-12

Study Completion Date

2020-06-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For patients admitted to the medical ward, it is often difficult to predict if their clinical condition will deteriorate, however subtle changes in vital signs are usually present 8 to 24 hours before a life-threatening event such as respiratory failure leading to ICU admission, or unanticipated cardiac arrest. Such adverse trends in clinical observations can be missed, misinterpreted or not appreciated as urgent. New continuous and wearable 24/7 clinical vital parameter monitoring systems offer a unique possibility to identify clinical deterioration before patients condition progress beyond the point-of-no-return, where adverse events are inevitable. The WARD-COPD project aims to determine the correlation between cardiopulmonary micro events and clinical adverse events during the first four days after hospital admission with acute exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease - Validation Study

NCT04248842

Chronic Obstructive Pulmonary Disease

COMPLETED

Wireless Assessment of Respiratory and Circulatory Distress in Chronic Obstructive Pulmonary Disease

NCT03467815

Chronic Obstructive Pulmonary Disease Dyspnea

COMPLETED

Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease

NCT02615795

Chronic Obstructive Pulmonary Disease, COPD

COMPLETED NA

A Digital Health Intervention to Promote Self-management in Patients With Chronic Obstructive Pulmonary Disease

NCT06850961

Chronic Obstructive Pulmonary Disease (COPD) Self-management Mobile Application +1 more

RECRUITING NA

Predicting Exacerbation of COPD With Wireless Telemonitoring

NCT02791451

COPD

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Obstructive Pulmonary Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Continuous monitoring system

Patients recruited will be continuously monitored with Isansys Lifetouch patch, Isansys wireless blood pressure monitor, Nonin WristOx 3150, Empatica E4, and Radiometer TCM5 FLEX monitor.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients admitted with AECOPD
* Recruitment and monitoring start is possible within 24 hours after admission

Exclusion Criteria

* Patient expected not to cooperate
* Patient allergic to plaster, plastic or silicone
* Active therapy withdrawn
* Patients with dementia or not able to give informed consent
* Patients with pacemaker or implantable cardioverter-defibrillator (ICD) unit
* Expected discharge within less than 24 hours from possible inclusion

Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No